MXPA04003910A - Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar. - Google Patents
Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.Info
- Publication number
- MXPA04003910A MXPA04003910A MXPA04003910A MXPA04003910A MXPA04003910A MX PA04003910 A MXPA04003910 A MX PA04003910A MX PA04003910 A MXPA04003910 A MX PA04003910A MX PA04003910 A MXPA04003910 A MX PA04003910A MX PA04003910 A MXPA04003910 A MX PA04003910A
- Authority
- MX
- Mexico
- Prior art keywords
- irbesartan
- medicaments
- preparation
- prevent
- pulmonary hypertension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
La invencion se refiere al uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o el tratamiento de hipertension arterial pulmonar o hipertension pulmonar.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0113936A FR2831446B1 (fr) | 2001-10-26 | 2001-10-26 | Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire |
PCT/FR2002/003439 WO2003035062A1 (fr) | 2001-10-26 | 2002-10-09 | Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04003910A true MXPA04003910A (es) | 2004-07-23 |
Family
ID=8868812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04003910A MXPA04003910A (es) | 2001-10-26 | 2002-10-09 | Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar. |
Country Status (24)
Country | Link |
---|---|
US (2) | US20040242567A1 (es) |
EP (1) | EP1441723B1 (es) |
JP (1) | JP4542777B2 (es) |
CN (1) | CN100418526C (es) |
AT (1) | ATE361071T1 (es) |
AU (1) | AU2002350832B2 (es) |
BR (1) | BR0213479A (es) |
CA (1) | CA2461625C (es) |
CY (1) | CY1106746T1 (es) |
DE (1) | DE60219940T2 (es) |
DK (1) | DK1441723T3 (es) |
EA (1) | EA007952B1 (es) |
ES (1) | ES2286304T3 (es) |
FR (1) | FR2831446B1 (es) |
HU (1) | HUP0401633A3 (es) |
IL (2) | IL161116A0 (es) |
IS (1) | IS2849B (es) |
MX (1) | MXPA04003910A (es) |
NO (1) | NO332313B1 (es) |
NZ (1) | NZ532130A (es) |
PL (1) | PL209263B1 (es) |
PT (1) | PT1441723E (es) |
WO (1) | WO2003035062A1 (es) |
ZA (1) | ZA200402696B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9808471B2 (en) | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US7811606B2 (en) | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
TR200301553A1 (tr) * | 2003-09-18 | 2005-10-21 | Nobel �La� Sanay�� Ve T�Caret A.�. | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
ATE493973T1 (de) | 2004-06-04 | 2011-01-15 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
WO2006067601A1 (en) * | 2004-12-23 | 2006-06-29 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation |
CN100367959C (zh) * | 2006-08-29 | 2008-02-13 | 陈俊云 | 一种含有依贝沙坦的药物 |
GB0617171D0 (en) * | 2006-08-31 | 2006-10-11 | Generics Uk Ltd | Novel compositions and methods |
CN117042763A (zh) * | 2021-03-23 | 2023-11-10 | 戴麦里克斯生物科学有限公司 | 炎性疾病的治疗 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
IE910913A1 (en) * | 1990-03-20 | 1991-09-25 | Sanofi Sa | N-substituted heterocyclic derivates, their preparation¹and pharmaceutical compositions containing them |
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
US5292741A (en) * | 1992-08-18 | 1994-03-08 | Merck & Co., Inc. | Macrocycles incorporating quinazolinones |
US20020068740A1 (en) | 1999-12-07 | 2002-06-06 | Mylari Banavara L. | Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
-
2001
- 2001-10-26 FR FR0113936A patent/FR2831446B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-09 NZ NZ532130A patent/NZ532130A/en not_active IP Right Cessation
- 2002-10-09 HU HU0401633A patent/HUP0401633A3/hu unknown
- 2002-10-09 US US10/492,804 patent/US20040242567A1/en not_active Abandoned
- 2002-10-09 DK DK02785535T patent/DK1441723T3/da active
- 2002-10-09 CN CNB028213041A patent/CN100418526C/zh not_active Expired - Fee Related
- 2002-10-09 EA EA200400438A patent/EA007952B1/ru not_active IP Right Cessation
- 2002-10-09 EP EP02785535A patent/EP1441723B1/fr not_active Expired - Lifetime
- 2002-10-09 DE DE60219940T patent/DE60219940T2/de not_active Expired - Lifetime
- 2002-10-09 PL PL368737A patent/PL209263B1/pl unknown
- 2002-10-09 IL IL16111602A patent/IL161116A0/xx unknown
- 2002-10-09 AT AT02785535T patent/ATE361071T1/de active
- 2002-10-09 JP JP2003537629A patent/JP4542777B2/ja not_active Expired - Fee Related
- 2002-10-09 CA CA2461625A patent/CA2461625C/en not_active Expired - Fee Related
- 2002-10-09 ES ES02785535T patent/ES2286304T3/es not_active Expired - Lifetime
- 2002-10-09 AU AU2002350832A patent/AU2002350832B2/en not_active Ceased
- 2002-10-09 WO PCT/FR2002/003439 patent/WO2003035062A1/fr active IP Right Grant
- 2002-10-09 PT PT02785535T patent/PT1441723E/pt unknown
- 2002-10-09 MX MXPA04003910A patent/MXPA04003910A/es active IP Right Grant
- 2002-10-09 BR BR0213479-9A patent/BR0213479A/pt not_active Application Discontinuation
-
2004
- 2004-03-25 IL IL161116A patent/IL161116A/en not_active IP Right Cessation
- 2004-03-29 IS IS7200A patent/IS2849B/is unknown
- 2004-04-06 ZA ZA2004/02696A patent/ZA200402696B/en unknown
- 2004-04-23 NO NO20041732A patent/NO332313B1/no not_active IP Right Cessation
-
2007
- 2007-07-19 CY CY20071100964T patent/CY1106746T1/el unknown
-
2009
- 2009-06-03 US US12/477,562 patent/US8088827B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03010134A (es) | Derivados de ciclohexan-1-4-diamina sustituidos. | |
TNSN05045A1 (en) | Indole or benzimidazole derivatives for modulating ikappab kinase | |
AU3652102A (en) | Compounds and their uses | |
MY134136A (en) | Novel compounds comprising jak3 kinase inhibitors | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
MXPA05011643A (es) | 5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension. | |
UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
GB0111186D0 (en) | Novel compounds | |
DK1456212T3 (da) | 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse | |
CY1106746T1 (el) | Χρηση του irbesartan για την προληψη ή τη θεραπεια της πνευμονικης υπερτασης | |
PL374080A1 (en) | Processes for the preparation of fibrinogen | |
AP2001002274A0 (en) | Rescorcinol derivatives. | |
WO2002060483A3 (en) | Perylenequinones for use as photosensitizers and sonosensitizers | |
AU2002350832A1 (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
MXPA04003544A (es) | Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina. | |
MXPA04005809A (es) | Inhibidores de proteinas quinasas. | |
MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
PT1651596E (pt) | Novos derivados de 4,4?-ditiobis-(3-aminobutano-1-sulfonatos) e composições que os contêm | |
MXPA04001205A (es) | Compuesto para eliminar y/o mitigar la anhedonia. | |
UA85187C2 (en) | 2-aminobenzoyl derivatives | |
TW200603801A (en) | Novel dialkoxy-imidazopyridines | |
SI1441723T1 (sl) | Uporaba irbesartana za preprečevanje ali zdravljenje pljučne hipertenzije | |
DK1490049T3 (da) | Citalopram til behandling af forhöjet blodtryk | |
AP1731A (en) | Use of an inhibitor of the renin-angiotensin system for the manufacture of a medicament or prevention of lipodystrophy syndorme. | |
IL160602A0 (en) | Polysubstituted indan-1-ol systems, processes for their preparation and their use as pharmaceuticals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of company name or juridical status | ||
FG | Grant or registration |